We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BDSX market cap is 214.56M. The company's latest EPS is USD -0.3585 and P/E is -4.10.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.49M | 14.67M | 14.82M | 17.93M | 18.15M |
| Operating Income | -7.17M | -6.87M | -11.02M | -8.24M | -8.59M |
| Net Income | -10.95M | -9.14M | -13.61M | -10.81M | -10.26M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 24.55M | 45.56M | 54.51M | 38.21M | 49.09M |
| Operating Income | -26.74M | -22.93M | -40.94M | -50.59M | -41.34M |
| Net Income | -30.73M | -31.35M | -43.16M | -65.45M | -52.15M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 86.79M | 99.1M | 87.2M | 115.84M | 102.74M |
| Total Liabilities | 88.23M | 94.52M | 92.7M | 79.58M | 74.89M |
| Total Equity | -1.45M | 4.58M | -5.5M | 36.26M | 27.86M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 41.63M | 121.07M | 76.1M | 92.91M | 99.1M |
| Total Liabilities | 76.21M | 79.9M | 56.37M | 72.3M | 94.52M |
| Total Equity | -228.54M | 41.17M | 19.73M | 20.61M | 4.58M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.59M | -22.87M | -15.32M | -33.88M | -44.55M |
| Investing | -20.06M | -23.06M | -273k | -2.27M | -2.56M |
| Financing | 7.4M | 29.13M | 791k | 52.09M | 52.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.73M | -21.37M | -28.22M | -44.97M | -22.87M |
| Investing | -1.87M | -2.93M | -2.55M | -3.53M | -23.06M |
| Financing | 22.97M | 81.13M | 1.26M | 58.88M | 29.13M |
| Market Cap | 214.56M |
| Price to Earnings Ratio | -4.10 |
| Price to Sales Ratio | 4.36 |
| Price to Cash Ratio | 8.14 |
| Price to Book Ratio | 46.69 |
| Dividend Yield | - |
| Shares Outstanding | 145.47M |
| Average Volume (1 week) | 164.16k |
| Average Volume (1 Month) | 258.78k |
| 52 Week Change | -16.67% |
| 52 Week High | 2.21 |
| 52 Week Low | 1.11 |
| Spread (Intraday) | 0.01 (0.68%) |
| Company Name | Biodesix Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.biodesix.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
